COMPANY
FDA-cleared device company Clinical Phase 3
Profile checked Oct 10, 2026
Keywords: Choroidal Neovascularization Macular Degeneration Age-Related Macular Degeneration Polypoid Choroidal Vasculopathy episcleral brachytherapy
Timeline
- Trial start Phase 3: Adjunct Episcleral Brachytherapy for PCV source ↗
- Trial start Not phased (device or behavioral study): Episcleral Brachytherapy for the Treatment of Wet AMD source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT02988895 | Episcleral Brachytherapy for the Treatment of Wet AMD | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | Aug 1, 2017 | May 26, 2023 (actual) |
| NCT05251636 | Adjunct Episcleral Brachytherapy for PCV | Phase 3 | Not yet recruiting | 2025-03 | 2026-09 (estimated) |
